đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903
Diabetic peripheral neuropathy(DPN) is a length dependent axonal neuropathy...
Status
Unknown
Location
Department of Endocrinology, PGIMER
Start Date
2022-05-01
Trial ID
NCT05162690
Treatments Being Tested
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
Patients with type 2 diabetes mellitus are exposed to an excessive heart fa...
Status
Terminated
Location
Hannover Medical School
Start Date
2016-04-27
Trial ID
NCT02728453
Treatments Being Tested
This two-phase study was to examine if 16 weeks of treatment with sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-24
Trial ID
NCT01477853
The purpose of this study is to demonstrate the efficacy and safety of vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01357252
Treatments Being Tested
This study aims to examine the involvement of KATP channels on the microvas...
Status
Terminated
Location
Royal Devon and Exeter NHS Foundation Trust
Start Date
2013-06
Trial ID
NCT01934816
Treatments Being Tested
Many people with type 2 diabetes cannot maintain target blood glucose level...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-05
Trial ID
NCT00099944
Treatments Being Tested